Severe Flu Season Provides an Opportunity for Molecular POC

Severe Flu Season Provides an Opportunity for Molecular POC

Molecular POC systems get their chance to prove themselves in a severe flu season, says analyst Rob Camp: "The gold standard for diagnostics is real-time PCR, but...PCR is time-consuming, because of the preparation and the complexity of its mechanism...So for a few years now, big biotech firms have been working on better solutions, employing nucleic acid amplification techniques that make PCR so accurate and engineering them into relatively tiny and simple packages"


World Vaccine Market Nears $28 Billion

World Vaccine Market Nears $28 Billion

Revenues earned by manufacturers of vaccines worldwide reached $27.6 billion in 2015, up from $24.7 billion in 2014 as sales in all segments expanded. This according to our most recent study Kalorama Information’s report: Vaccines 2016:World Market Analysis Kalorama finds that sales of pediatric vaccines constitute the larger market according to the report, accounting for 57.6% of the total vaccines market.. In 2015, global sales of pediatric vaccines exceeded $16.8 billion, increasing by 15.8% ...